These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 22191153)
1. Exploring the hormone replacement therapy debate. Garad R; Burger H; Davison S Aust Nurs J; 2011 Nov; 19(5):30-3. PubMed ID: 22191153 [No Abstract] [Full Text] [Related]
2. Hormone replacement therapy: the right choice for your patient? Leong SL; Erickson DR; Pees RC J Fam Pract; 2005 May; 54(5):428-36. PubMed ID: 15865901 [No Abstract] [Full Text] [Related]
3. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study]. Canonico M; Scarabin PY Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161 [No Abstract] [Full Text] [Related]
4. Transdermal estradiol and testosterone transfer in man: existence, models, and strategies for prevention. Busse KL; Maibach HI Skin Pharmacol Physiol; 2011; 24(2):57-66. PubMed ID: 21088452 [TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal hormone replacement therapy--is there a cause of worry?]. Skouby SO; Wilken-Jensen C; Jespersen J; Pedersen AT; Ottesen BS Ugeskr Laeger; 2002 Aug; 164(34):3974-5. PubMed ID: 12212482 [No Abstract] [Full Text] [Related]
6. [Benefits and risks of the andropause treatment]. Martits AM; Costa EM Rev Assoc Med Bras (1992); 2005; 51(2):67-70. PubMed ID: 15947815 [No Abstract] [Full Text] [Related]
7. Hormonal replacement therapy in breast cancer. Pritchard KI Ann Oncol; 2002; 13 Suppl 4():73-80. PubMed ID: 12401670 [No Abstract] [Full Text] [Related]
8. The endocrinology of gonadal involution: menopause and andropause. Lamberts SW Ann Endocrinol (Paris); 2003 Apr; 64(2):77-81. PubMed ID: 12773935 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in menopause and lung cancer: an update. La Vecchia C Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859 [No Abstract] [Full Text] [Related]
10. Update: the latest on hormone replacement therapy. Packin GS J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S2-5. PubMed ID: 11105456 [TBL] [Abstract][Full Text] [Related]
12. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C; Reeves G Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
13. [Hormone therapy during menopause and risk of cardiovascular disease]. Pedersen AT; Ottesen BS Ugeskr Laeger; 2002 Apr; 164(18):2414. PubMed ID: 12024849 [No Abstract] [Full Text] [Related]
14. Hormone replacement therapy--finally, good data. Rosenberg L; Hoffman M S Afr Med J; 2004 Jan; 94(1):26-7. PubMed ID: 14971225 [No Abstract] [Full Text] [Related]
17. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use]. Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514 [TBL] [Abstract][Full Text] [Related]
19. [Hormone replacement therapy in menopause and cardiovascular disease--one more time]. Os I; Tonstad S Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1808-10. PubMed ID: 12362695 [No Abstract] [Full Text] [Related]
20. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC; Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]